A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specific antigen (PSA) responses, accumulating clinical d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Boinapally, Srikanth, Ahn, Hye-Hyun, Cheng, Bei, Brummet, Mary, Nam, Hwanhee, Gabrielson, Kathleen L., Banerjee, Sangeeta R., Minn, Il, Pomper, Martin G.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007718/
https://ncbi.nlm.nih.gov/pubmed/33782486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86551-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares